德泰新能源集團(00559.HK)以4378.15萬港元收購中基長壽科學的2.08%股份
格隆匯9月13日丨德泰新能源集團(00559.HK)宣佈,於2021年9月13日,公司(作為買方)與賣方(作為賣方)訂立買賣協議,據此,公司同意向賣方收購其所持中基長壽科學(00767.HK)的2.08%股份,代價為4378.15萬港元,相當於每股銷售股份約0.5428港元。代價將由公司於完成時以抵銷方式向賣方支付。為方便抵銷,債務之全部金額將於完成時由德泰財務轉讓予公司。收購事項已於買賣協議日期完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.